Health Food Functional Evaluation Experiments: Testing Scope, Methods, and Regulatory Applications

Health food functional evaluation experiments are standardized in vivo animal studies and human feeding trials used to scientifically substantiate the physiological function claims of health foods and dietary supplements. Covering claims such as immune support, fatigue relief, antioxidant activity, and blood lipid or glucose regulation, these experiments are a core requirement for health food registration and filing in regulated markets. Accredited third-party laboratories conduct these studies under GLP-aligned quality systems to ensure that the resulting data are reliable, reproducible, and acceptable to regulatory authorities.

Technical Overview

Health food functional evaluation experiments refer to a systematic set of laboratory animal studies and human intervention trials designed to verify whether a health food product delivers its declared physiological functions. These experiments form the scientific backbone of health food registration systems in China and several other jurisdictions, where a product may not carry a function claim unless the claimed effect has been demonstrated under standardized testing protocols.

The evaluation framework is built on three pillars: animal function experiments conducted in SPF-grade laboratory animals, human feeding trials performed under ethical oversight, and auxiliary safety observations recorded throughout the study period. Test designs must follow recognized dose-response principles, typically including a negative control group and at least three dose levels corresponding to multiples of the recommended human daily intake. The applicable protocols are defined in the technical norms and functional evaluation guidelines issued by Chinese health authorities, complemented by the GB 15193 series for associated food safety toxicology testing and GB 14925 for laboratory animal housing facilities.

Functional evaluation differs fundamentally from routine physicochemical or microbiological quality testing. Rather than confirming composition and purity, it demonstrates biological efficacy in living systems, generating the pivotal efficacy data required for regulatory dossier submission, claim substantiation, and post-market re-evaluation.

Testing Samples

Finished Health Food Products

Complete market-ready or registration-stage formulations submitted in their final dosage form, including tablets, hard and soft capsules, granules, powders, oral liquids, and jellies. For each submission, representative samples from a defined production batch are supplied together with the product formula, recommended daily dosage, process description, and shelf-life data, ensuring that the tested material matches the article of commerce.

Raw Materials and Functional Ingredients

Functional ingredients and intermediate materials such as plant and herbal extracts, bioactive peptides, probiotic preparations, polysaccharides, dietary fibers, vitamins, and minerals. These samples support preclinical screening, dose-finding studies, and formulation optimization before a finished product is committed to full-scale functional testing.

Human Trial Preparations

For functions requiring human feeding trials, matched test and placebo products are prepared with identical appearance, flavor, and packaging, coded and blinded so that neither investigators nor subjects can distinguish them. Sample logistics, randomization kits, and distribution records must comply with the trial protocol and be verifiable during audits.

Testing Items

Functional evaluation covers the catalog of permitted health function claims. Each claim is linked to a specific protocol with defined endpoints, and typical testing items include the following:

• Immune function enhancement: spleen and thymus indexes, ConA-induced lymphocyte proliferation, delayed-type hypersensitivity reaction, serum hemolysin and antibody-forming cell assays, natural killer cell activity, and carbon clearance capacity.
• Alleviation of physical fatigue: weight-loaded swimming endurance, serum urea nitrogen, hepatic and muscle glycogen, and blood lactate kinetics.
• Sleep improvement: direct sleep observation, pentobarbital sodium-induced sleep latency and duration, and subthreshold hypnotic potentiation.
• Antioxidant function: malondialdehyde content, superoxide dismutase and glutathione peroxidase activities in serum and liver, and aging model validation.
• Auxiliary blood lipid regulation: total cholesterol, triglycerides, and high-density lipoprotein cholesterol in diet-induced hyperlipidemia models.
• Auxiliary blood glucose regulation: fasting glucose, glucose tolerance tests, and insulin measurements in chemically induced diabetic animal models.
• Auxiliary blood pressure reduction: systolic and diastolic blood pressure monitoring in hypertensive rat models.
• Chemical liver injury protection: serum alanine aminotransferase and aspartate aminotransferase, hepatic histopathology, and hepatic malondialdehyde in induced injury models.
• Increased bone density: bone mineral density measurement by dual-energy X-ray absorptiometry, bone calcium content, and biomechanical strength in ovariectomized or low-calcium models.
• Gastrointestinal function improvement: intestinal propulsion time, defecation frequency, stool characteristics, and gut microbiota analysis.
• Improvement of nutritional anemia: hemoglobin, red blood cell counts, and hematocrit in iron-deficiency or induced anemia models.
• Weight control: body weight, body fat ratio, and energy metabolism measurements.
• Auxiliary memory improvement: step-down, step-through, and water maze behavioral tests assessing acquisition, retention, and recall performance.
• Human-trial-based claims: relief of visual fatigue, improvement of skin hydration and oil content, and other claims requiring subjective symptom scoring combined with objective biomarkers.

Throughout all functional studies, auxiliary observations are recorded, including body weight changes, food and water intake, organ coefficients, and any abnormal clinical signs, so that efficacy conclusions are interpreted together with the safety profile.

Testing Methods

Animal Experiment Design

Animal studies use SPF-grade mice or rats sourced from qualified suppliers and housed in barrier facilities meeting GB 14925 requirements. A standard design includes a negative control group and three dose groups set at multiples of the recommended human intake, commonly tenfold, thirtyfold, and one-hundredfold after body-surface-area conversion. Animals are randomized by body weight, and investigators evaluating outcomes are blinded to group allocation. The feeding period is typically thirty days, extended where the specific protocol requires longer exposure, and both sexes are included unless the protocol justifies otherwise.

Human Feeding Trials

Claims requiring human demonstration are evaluated through controlled feeding trials conducted under ethics committee approval and informed consent. Protocols define strict inclusion and exclusion criteria, baseline diagnostic indicators, a randomized and preferably double-blind placebo-controlled design, and trial durations commonly of thirty to sixty days depending on the claimed function. Efficacy judgment combines symptom or functional scoring with measurable clinical and biochemical indicators, and subjects showing adverse reactions are managed according to predefined safety procedures.

Endpoint Assays and Instrumentation

Endpoints are measured using validated analytical platforms: enzymatic and colorimetric assays for biochemical markers, flow cytometry or spectrophotometry for immune cell function, behavioral apparatus for cognitive and fatigue testing, absorptiometry for bone density, and standardized histopathological examination of tissues. All instruments are calibrated and maintained under documented quality systems consistent with ISO/IEC 17025 laboratory competence requirements.

Data Analysis and Judgment Criteria

Results are analyzed with appropriate statistical methods, typically analysis of variance or non-parametric equivalents with post-hoc comparisons against the negative control. A positive finding generally requires a statistically significant, dose-related improvement in the primary endpoint without adverse effects on body weight or general condition. Many protocols require at least two concordant positive endpoints in animal studies, and human trials require improvements over baseline and placebo that are both statistically significant and clinically meaningful. Any negative safety observation during the study must be addressed before an efficacy conclusion is accepted.

Applications

Functional evaluation experiment reports serve multiple regulatory and commercial purposes:

• Registration dossiers: providing the pivotal efficacy data required for health food product registration and the approval of function claims in China and comparable regulated markets.
• Research and development: guiding formulation optimization, functional ingredient selection, and the determination of effective and safe dosage ranges before full commercialization.
• Claim substantiation: supplying scientific documentation that supports labeling statements and marketing materials, reducing regulatory and advertising compliance risk.
• International market access: generating study data that can be referenced, together with local requirements, when products are positioned for export or cross-border registration.
• Post-market surveillance and re-evaluation: supporting periodic functional re-verification required by regulators after products enter the market.
• Scientific publication and industry benchmarking: contributing reproducible evidence for peer-reviewed literature, trade documentation, and comparative product positioning.

FAQ

Which health functions require human trials in addition to animal studies?

Claims such as relief of visual fatigue and improvement of skin hydration are primarily demonstrated through human feeding trials because the endpoints are inherently subjective and human-specific. Most other claims in the permitted catalog can be substantiated with animal experiments alone, although some functions use animal data together with optional or conditional human confirmation depending on the applicable technical guideline version and product characteristics.

How long does a complete functional evaluation take?

A typical thirty-day animal feeding study, including acclimatization, endpoint assays, and report preparation, generally requires two to three months. Human feeding trials usually require three to six months from ethics approval and recruitment through final reporting. Products claiming multiple functions require separate protocols and testing cycles for each claim.

How many sample batches are needed for testing?

Regulatory submissions normally require samples from a single representative production batch, supplied in quantities sufficient for all dose groups, retention samples, and analytical verification. The batch must be produced under the declared process, and its quality must meet the product standard before functional testing begins.

Must functional experiments be performed in a specific type of laboratory?

Yes. Regulatory authorities require that functional evaluation, human trials, and the associated toxicological studies be carried out in laboratories qualified for such work, such as accredited third-party laboratories or institutions holding the relevant national qualifications. Study quality systems are expected to align with GLP principles and ISO/IEC 17025, and human trials must have documented ethics approval.

Can one set of experiments support several function claims?

No. Each declared function follows a dedicated protocol with its own models, endpoints, and judgment criteria. A product seeking two claims must complete two independent evaluations, although shared safety and quality data may be referenced across submissions to avoid duplicate work.